3 more months of vacation

Quote






























Most anyone would enjoy the down time you folks have had and possibly will still have going into 2017, just make sure you remember how to introduce yourself at the front desk of a busy practice with a gate keeper who could give a shit that you're with genentech.
As one who isn't PC - Merry Christmas, Happy Hanukkah and Happy New Year to all. to the rest, whatever.
 












anonymous said:
Most anyone would enjoy the down time you folks have had and possibly will still have going into 2017, just make sure you remember how to introduce yourself at the front desk of a busy practice with a gate keeper who could give a shit that you're with genentech.
As one who isn't PC - Merry Christmas, Happy Hanukkah and Happy New Year to all. to the rest, whatever.
Click to expand...

Gives us more time to "profile". Haha, that's a good one. Like Mc Donalds..."I'm lovin it".
 






Enjoy the time off folks as FDA read SSF riot acts in 2016 over GNE's arrogance, pushing the envelopes with recent drug submissions and deplorable quality system which explains why so many Quality VPs left in 2015 and 2016 starting with JP and recently RH.

And y'all know what FDA said about the Ocre manufacturing and quality issues - don't take it lightly especially what FDA told Roche last year.
 
























anonymous said:
delays might go until end of year or beyond.this is serious stuff.I'm hearing. This has a very good chance of not resolving by April.
Click to expand...

Well nobody knows - even PTR bozos (regulatory dept) holed up in B32.

Reality is that GNE pissed off FDA 1 too many times not to mention Quality/Regulatory/Mfg's arrogance and shortcuttings galore, and especially "pushing" FDA on the last couple of Onc drugs submissions. Well FDA may now be saying big FU to GNE as Ocre ain't like the life saving (even couple of months of "survival rate" is big deal) Onc drugs.

Y'all enjoy the country club lifestyle and maybe look for other job if not approved by end of Sept or Q3 as this sort of regulatory drama tends to last longer than PR dept lead y'all to believe...
 
















































Top Bottom
Back
Quote